Does Long-Term Natalizumab (NTZ) Therapy Normalize Brain Atrophy Rates and Quality of Life (QOL) in Relapsing Remitting Multiple Sclerosis (RRMS)?

Clinical trial NCT02588053 · COMPLETED

Trial details

NCT number: NCT02588053
Sponsor: University of Colorado, Denver
Status: COMPLETED
Study type: OBSERVATIONAL

Multiple Sclerosis

Start date: 2014-07-01
Primary completion: 2018-12-01
Enrollment: 85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.